Sustained-release formulations comprising peptides,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/44 (2006.01) A61K 9/00 (2006.01) A61K 9/70 (2006.01) A61K 31/20 (2006.01) A61K 38/00 (2006.01) A61K 38/13 (2006.01) A61K 38/17 (2006.01)

Patent

CA 2336879

A pharmaceutical and/or veterinary formulation comprising about 2-30 %(w/w) (on an active basis) of at least one active agent, about 0.5-20.0 %(w/w) of a pore-forming agent and the balance stearin. Such formulations provide sustained release of the at least one active agent in humans and other animals for periods of 7 days up to about 2 years.

L'invention porte sur une préparation pharmaceutique et/ou vétérinaire comportant environ de 2 à 30 % en poids (sur une base active) d'au moins un principe actif, environ 0,5 à 20 % en poids d'un porogène, et le reliquat de stéarine. Ces préparations permettent la libération continue d'au moins un principe actif chez l'homme et certains animaux sur des périodes allant de 7 jours à environ 2 ans.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sustained-release formulations comprising peptides,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sustained-release formulations comprising peptides,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release formulations comprising peptides,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1515483

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.